Maximilian Schonung
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.
Journal: Blood
Published: September 26, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia.
Journal: Blood cancer discovery
Published: July 02, 2025
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study.
Journal: British journal of haematology
Published: May 27, 2025
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard.
Journal: Nucleic acids research
Published: December 14, 2024
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.
Journal: Blood cancer discovery
Published: October 03, 2024
Dynamic DNA methylation reveals novel cis-regulatory elements in mouse hematopoiesis.
Journal: Experimental hematology
Published: September 02, 2022
DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients.
Journal: International journal of cancer
Published: July 15, 2022
DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy.
Journal: International journal of cancer
Published: April 20, 2022
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.
Journal: JHEP reports : innovation in hepatology
Published: April 02, 2021
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Journal: Blood advances
Published: December 30, 2020
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Journal: Nature cancer
Published: November 20, 2020
Last Updated: 09/26/2026